{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:58Z","timestamp":1793237038179,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C14\/20\/095"],"award-info":[{"award-number":["C14\/20\/095"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.tcm.2022.02.005","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:15:08Z","timestamp":1644974108000},"page":"357-366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":533,"title":["Myocardial ischemia-reperfusion injury and the influence of inflammation"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4763-7426","authenticated-orcid":false,"given":"Michiel","family":"Algoet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Himmelreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willy","family":"Gsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matic","family":"Pusovnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Van den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Oosterlinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2022.02.005_bib0001","unstructured":"GLOBAL STATUS REPORT on noncommunicable diseases 201 4 \u201cAttaining the nine global noncommunicable diseases targets; a shared responsibility.\u201d"},{"issue":"20","key":"10.1016\/j.tcm.2022.02.005_bib0002","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2022.02.005_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102474","article-title":"Role of macrophages in cardioprotection","volume":"20","author":"Yap","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.tcm.2022.02.005_bib0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.005_bib0006","first-page":"631","article-title":"Clec4e-receptor signaling in myocardial repair after ischemia-reperfusion injury","volume":"6","author":"Veltman","year":"2021","journal-title":"JACC"},{"key":"10.1016\/j.tcm.2022.02.005_bib0007","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.tcm.2022.02.005_bib0008","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2022.02.005_bib0009","first-page":"262","article-title":"The role of calcium in the ischemic myocardium","volume":"102","author":"Nayler","year":"1981","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/1.3.201","article-title":"Morphological changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (Calcium Paradox)","volume":"1","author":"Zimmerman","year":"1967","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0011","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1172\/JCI112906","article-title":"Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts","volume":"79","author":"Kusuoka","year":"1987","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.005_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.tcm.2022.02.005_bib0013","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2022.02.005_bib0014","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.jacc.2018.08.2147","article-title":"Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: jacc macrophage in CVD Series (Part 2)","volume":"72","author":"Moore","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2022.02.005_bib0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2022.02.005_bib0016","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2022.02.005_bib0017","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving Inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2022.02.005_bib0018","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat Immunol;"},{"key":"10.1016\/j.tcm.2022.02.005_bib0019","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.005_bib0020","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1371\/journal.pone.0008852","article-title":"Macrophage plasticity in experimental atherosclerosis","volume":"5","author":"Khallou-Laschet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tcm.2022.02.005_bib0021","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/HCO.0000000000000158","article-title":"Inflammation in cardiac injury, repair and regeneration","volume":"30","author":"Frangogiannis","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.005_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacbts.2021.07.001","article-title":"Clec4e-receptor signaling in myocardial repair after ischemia-reperfusion injury","volume":"6","author":"Veltman","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.tcm.2022.02.005_bib0023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/cmi.2011.58","article-title":"C-type lectin receptor-induced NF-\u03baB activation in innate immune and inflammatory responses","volume":"9","author":"Kingeter","year":"2012","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.005_bib0024","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/138920112798868782","article-title":"Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches","volume":"13","author":"Braunersreuther","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"issue":"26","key":"10.1016\/j.tcm.2022.02.005_bib0025","doi-asserted-by":"crossref","first-page":"19133","DOI":"10.1074\/jbc.M701917200","article-title":"Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion","volume":"282","author":"Robin","year":"2007","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.tcm.2022.02.005_bib0026","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.192.7.1001","article-title":"Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes","volume":"192","author":"Zorov","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.tcm.2022.02.005_bib0027","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"49","key":"10.1016\/j.tcm.2022.02.005_bib0028","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.tcm.2022.02.005_bib0029","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2022.02.005_bib0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/pr.107.06002","article-title":"Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning","volume":"59","author":"Ferdinandy","year":"2007","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0031","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s1145-002-0906-2","article-title":"Increased cardiomyocyte apoptosis following ischemia and reperfusion in diet-induced hypercholesterolemia: Relation to Bcl-2 and Bax proteins and caspase-3 activity","volume":"37","author":"Wang","year":"2002","journal-title":"Lipids"},{"key":"10.1016\/j.tcm.2022.02.005_bib0032","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.tcm.2022.02.005_bib0033","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/oby.21654","article-title":"Reactive oxygen species and oxidative stress in obesity\u2014recent findings and empirical approaches","volume":"24","author":"McMurray","year":"2016","journal-title":"Obesity"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0034","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jtcvs.2013.02.016","article-title":"Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning","volume":"145","author":"Oosterlinck","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.tcm.2022.02.005_bib0035","series-title":"Annals of the New York Academy of Sciences","first-page":"244","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","author":"Franceschi","year":"2000"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.01.009","article-title":"An Acetylation Switch of the NLRP3 Inflammasome Regulates Aging-Associated Chronic Inflammation and Insulin Resistance","volume":"31","author":"He","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.tcm.2022.02.005_bib0037","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1042\/CS20191213","article-title":"Inflammageing in the cardiovascular system: mechanisms, emerging targets, and novel therapeutic strategies","volume":"134","author":"Liu","year":"2020","journal-title":"Clin Sci"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.005_bib0038","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1084\/jem.20140639","article-title":"Progressive replacement of embryo-derived cardiac macrophages with age","volume":"211","author":"Molawi","year":"2014","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.005_bib0039","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ Res"},{"issue":"6327","key":"10.1016\/j.tcm.2022.02.005_bib0040","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.005_bib0041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.005_bib0042","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/clc.22988","article-title":"Rationale and design of the Virginia Commonwealth University\u2013Anakinra Remodeling Trial-3 (VCU-ART3): a randomized, placebo-controlled, double-blinded, multicenter study","volume":"41","author":"van Tassell","year":"2018","journal-title":"Clin Cardiol"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.005_bib0043","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.tcm.2022.02.005_bib0044","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.tcm.2022.02.005_bib0046","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0047","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: The MRC-ILA Heart Study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.tcm.2022.02.005_bib0048","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: A pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2022.02.005_bib0049","series-title":"Colchicine for the treatment of coronary artery disease. Trends in Cardiovascular Medicine","author":"Aimo","year":"2020"},{"issue":"34","key":"10.1016\/j.tcm.2022.02.005_bib0050","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.005_bib0051","first-page":"431","article-title":"Selective interleukin-6 trans-signaling blockade is more effective than panantagonism in reperfused myocardial infarction","volume":"6","author":"George","year":"2021","journal-title":"JACC"},{"issue":"15","key":"10.1016\/j.tcm.2022.02.005_bib0052","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute st-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0053","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2022.02.005_bib0054","first-page":"74","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction","author":"Gao","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.tcm.2022.02.005_bib0055","first-page":"2020","article-title":"Oridonin attenuates myocardial ischemia\/reperfusion injury via downregulating oxidative stress and NLRP3 inflammasome pathway in mice","author":"Lu","year":"2020","journal-title":"Evid-Based Complem Alternat Med"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0056","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: Mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.tcm.2022.02.005_bib0057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pharmthera.2009.01.002","article-title":"Statins and cardioprotection - more than just lipid lowering?","volume":"122","author":"Ludman","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.005_bib0058","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1002\/eji.200636567","article-title":"Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases","volume":"36","author":"Ghittoni","year":"2006","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0059","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0735-1097(99)00318-6","article-title":"Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction","volume":"34","author":"Soejima","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.tcm.2022.02.005_bib0060","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCRESAHA.121.318005","article-title":"Immune cells and immunotherapy for cardiac injury and repair","volume":"128","author":"Rurik","year":"2021","journal-title":"Circ Res"},{"issue":"16","key":"10.1016\/j.tcm.2022.02.005_bib0061","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/eurheartj\/ehv597","article-title":"EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention","volume":"37","author":"Gibson","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2022.02.005_bib0062","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/ijms18091897","article-title":"Mitochondrial-targeted antioxidant maintains blood flow, mitochondrial function, and redox balance in old mice following prolonged limb ischemia","volume":"18","author":"Miura","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0063","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1007764616025","article-title":"Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction","volume":"12","author":"Singh","year":"1998","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.tcm.2022.02.005_bib0064","series-title":"The effect of coenzyme QIO on infarct size in a rabbit model of ischemia\/reperfusion. Vol. 32","author":"Bimbaum","year":"1996"},{"key":"10.1016\/j.tcm.2022.02.005_bib0065","series-title":"Efficacy and safety of cyclosporine in acute myocardial infarction: a systematic review and meta-analysis. Vol. 9","author":"Rahman","year":"2018"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0066","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1152\/physrev.00024.2010","article-title":"Myocardial AKT: the omnipresent nexus","volume":"91","author":"Sussman","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.tcm.2022.02.005_bib0067","doi-asserted-by":"crossref","unstructured":"Bernardi P, cardiology FDL-J of molecular and cellular, 2015 undefined. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. Elsevier.","DOI":"10.1016\/j.yjmcc.2014.09.023"},{"issue":"14","key":"10.1016\/j.tcm.2022.02.005_bib0068","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/01.CIR.0000126294.81407.7D","article-title":"Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection","volume":"109","author":"Hausenloy","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.tcm.2022.02.005_bib0069","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcm.2005.07.005","article-title":"Cardiomyocyte-specific overexpression of nitric oxide synthase 3: impact on left ventricular function and myocardial infarction","volume":"15","author":"Bloch","year":"2005","journal-title":"Trends Cardiovasc Med"},{"issue":"19","key":"10.1016\/j.tcm.2022.02.005_bib0070","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.108.805242","article-title":"Cardioprotection: Nitric oxide, protein kinases, and mitochondria","volume":"118","author":"Keusch","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0071","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1152\/japplphysiol.90470.2008","article-title":"Physiology of the aging vasculature: inflammation and endothelial dysfunction during aging: role of NF-\u03baB","volume":"105","author":"Csiszar","year":"2008","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.005_bib0072","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00424-016-1922-6","article-title":"Cardioprotection by remote ischemic conditioning and its signal transduction","volume":"469","author":"Kleinbongard","year":"2017","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.tcm.2022.02.005_bib0073","doi-asserted-by":"crossref","first-page":"12660","DOI":"10.1038\/s41598-017-12833-2","article-title":"Potential humoral mediators of remote ischemic preconditioning in patients undergoing surgical coronary revascularization","volume":"7","author":"Gedik","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0074","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.117.306878","article-title":"Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways","volume":"117","author":"Skyschally","year":"2015","journal-title":"Circ Res"},{"issue":"14","key":"10.1016\/j.tcm.2022.02.005_bib0075","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.105.558122","article-title":"Postconditioning the human heart","volume":"112","author":"Staat","year":"2005","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.tcm.2022.02.005_bib0076","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2012.03.026","article-title":"Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction","volume":"59","author":"Thuny","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0077","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-013-0383-8","article-title":"Postconditioning attenuates no-reflow in STEMI patients","volume":"108","author":"Mewton","year":"2013","journal-title":"Basic Res Cardiol"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.005_bib0078","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/CIRCRESAHA.118.314060","article-title":"NHLBI-sponsored randomized trial of postconditioning during primary percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"124","author":"Traverse","year":"2019","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.005_bib0079","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.107.729780","article-title":"Long-term benefit of postconditioning","volume":"117","author":"Thibault","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2022.02.005_bib0080","unstructured":"The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic Postconditioning During Primary PCI - American College of Cardiology [Internet]. [cited 2021 May 17]. Available from: https:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2016\/03\/29\/22\/46\/danami-3-ipost."},{"issue":"1","key":"10.1016\/j.tcm.2022.02.005_bib0081","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/heartjnl-2019-314952","article-title":"Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction","volume":"106","author":"Nepper-Christensen","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2022.02.005_bib0082","doi-asserted-by":"crossref","unstructured":"B\u00f8tker HE, Kharbanda R, Schmidt MR, B\u00f8ttcher M, Kaltoft AK, Terkelsen CJ, et\u00a0al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Vol. 375, www.thelancet.com. 2010.","DOI":"10.1016\/S0140-6736(09)62001-8"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0083","first-page":"656","article-title":"Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT","volume":"3","author":"Munk","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0084","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-018-0672-3","article-title":"Randomized controlled trial of remote ischaemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI)","volume":"113","author":"Gaspar","year":"2018","journal-title":"Basic Res Cardiol"},{"issue":"10207","key":"10.1016\/j.tcm.2022.02.005_bib0085","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(19)32039-2","article-title":"Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2\/ERIC-PPCI): a single-blind randomised controlled trial","volume":"394","author":"Hausenloy","year":"2019","journal-title":"Lancet North Am Ed"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0086","article-title":"Multiparametric imaging of organ system interfaces","volume":"10","author":"Vandoorne","year":"2017","journal-title":"Circulationg"},{"issue":"15","key":"10.1016\/j.tcm.2022.02.005_bib0087","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","article-title":"Imaging systemic inflammatory networks in ischemic heart disease","volume":"65","author":"Nahrendorf","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0088","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm1700","article-title":"Simultaneous PET-MRI: a new approach for functional and morphological imaging","volume":"14","author":"Judenhofer","year":"2008","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.005_bib0089","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/CIRCULATIONAHA.107.737890","article-title":"In vivo monitoring of inflammation after cardiac and cerebral ischemia by 19F magnetic resonance imaging","volume":"118","author":"Flogel","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2022.02.005_bib0090","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/molecules22060881","article-title":"Current perspective on in vivo molecular imaging of immune cells","volume":"22","author":"Seth","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.tcm.2022.02.005_bib0091","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.isci.2019.09.022","article-title":"Longitudinal in vivo assessment of host-microbe interactions in a murine model of pulmonary aspergillosis","volume":"20","author":"Saini","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.tcm.2022.02.005_bib0092","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/biomedicines9020212","article-title":"Imaging inflammation with positron emission tomography","volume":"9","author":"Iking","year":"2021","journal-title":"Biomedicines"},{"issue":"37","key":"10.1016\/j.tcm.2022.02.005_bib0093","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1093\/eurheartj\/ehaa598","article-title":"Molecular imaging-guided repair after acute myocardial infarction by targeting the chemokine receptor CXCR4","volume":"41","author":"Hess","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2022.02.005_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms14064","article-title":"Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease","volume":"8","author":"Keliher","year":"2017","journal-title":"Nat Commun"},{"issue":"47","key":"10.1016\/j.tcm.2022.02.005_bib0095","doi-asserted-by":"crossref","first-page":"77807","DOI":"10.18632\/oncotarget.12799","article-title":"Somatostatin receptor based PET\/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.tcm.2022.02.005_bib0096","first-page":"1079","article-title":"Combined postconditioning with ischemia and cyclosporine-a restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium","volume":"20","author":"Badalzadeh","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.tcm.2022.02.005_bib0097","article-title":"Diabetic cardiomyopathy attenuated the protective effect of ischaemic post-conditioning against ischaemia-reperfusion injury in the isolated rat heart model","author":"Kurian","year":"2020","journal-title":"Arch Physiol Biochem"},{"issue":"6","key":"10.1016\/j.tcm.2022.02.005_bib0098","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s11011-019-00484-3","article-title":"Age-related difference in protective effect of early post-conditioning on ischemic brain injury: possible involvement of MAP-2\/Synaptophysin role","volume":"34","author":"Samandari","year":"2019","journal-title":"Metab Brain Dis"},{"issue":"15","key":"10.1016\/j.tcm.2022.02.005_bib0099","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.2016.3609","article-title":"Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial","volume":"315","author":"O\u2019Donoghue","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.tcm.2022.02.005_bib0100","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"9626","key":"10.1016\/j.tcm.2022.02.005_bib0101","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(08)60763-1","article-title":"Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Tardif","year":"2008","journal-title":"Lancet North Am Ed"},{"issue":"30","key":"10.1016\/j.tcm.2022.02.005_bib0102","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: A double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.tcm.2022.02.005_bib0103","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/jama.2013.282836","article-title":"Varespladib and cardiovascular events in patients with an acute coronary syndrome: The VISTA-16 randomized clinical trial","volume":"311","author":"Nicholls","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.tcm.2022.02.005_bib0104","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/heartjnl-2013-304845","article-title":"The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial","volume":"100","author":"Hausenloy","year":"2014","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.tcm.2022.02.005_bib0105","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJMoa071142","article-title":"Effect of cyclosporine on reperfusion injury in acute myocardial infarction","volume":"359","author":"Piot","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.tcm.2022.02.005_bib0106","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2009.10.052","article-title":"Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction","volume":"55","author":"Mewton","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.tcm.2022.02.005_bib0107","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1111\/1755-5922.12010","article-title":"The Effect of prethrombolytic cyclosporine-a injection on clinical outcome of acute anterior st-elevation myocardial infarction","volume":"31","author":"Ghaffari","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.tcm.2022.02.005_bib0108","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/ALN.0000000000000331","article-title":"Cyclosporine protects the heart during aortic valve surgery","volume":"121","author":"Chiari","year":"2014","journal-title":"Anesthesiology"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173822000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:03:30Z","timestamp":1760936610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173822000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1050173822000299"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial ischemia-reperfusion injury and the influence of inflammation","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}